Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis / Minelli, Roberta; Braverman, Le; Valli, Ma; Schianchi, C; Pedrazzoni, Mario; Fiaccadori, F; Salvi, M; Magotti, Mg; Roti, E.. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - 50:(1999), pp. 95-100.

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis

MINELLI, Roberta;PEDRAZZONI, Mario;
1999-01-01

Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis / Minelli, Roberta; Braverman, Le; Valli, Ma; Schianchi, C; Pedrazzoni, Mario; Fiaccadori, F; Salvi, M; Magotti, Mg; Roti, E.. - In: CLINICAL ENDOCRINOLOGY. - ISSN 0300-0664. - 50:(1999), pp. 95-100.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1458548
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 5
social impact